KeyCorp Boosts Encompass Health (NYSE:EHC) Price Target to $120.00

Encompass Health (NYSE:EHC) had its price objective increased by investment analysts at KeyCorp from $117.00 to $120.00 in a research report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. KeyCorp’s price target suggests a potential upside of 20.76% from the company’s previous close.

Several other research firms have also recently commented on EHC. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Truist Financial reiterated a “buy” rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Royal Bank of Canada lifted their price target on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. StockNews.com downgraded Encompass Health from a “buy” rating to a “hold” rating in a report on Friday, February 7th. Finally, Barclays boosted their target price on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. One analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health has an average rating of “Buy” and an average price target of $107.67.

Encompass Health Stock Performance

Shares of EHC stock opened at $99.37 on Monday. Encompass Health has a 52 week low of $72.38 and a 52 week high of $104.55. The firm has a 50 day moving average of $96.14 and a two-hundred day moving average of $95.41. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $10.01 billion, a PE ratio of 22.28, a P/E/G ratio of 1.18 and a beta of 0.90.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. On average, research analysts predict that Encompass Health will post 4.76 EPS for the current fiscal year.

Institutional Trading of Encompass Health

Large investors have recently bought and sold shares of the business. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after buying an additional 137 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares during the period. Avior Wealth Management LLC purchased a new stake in shares of Encompass Health during the third quarter worth approximately $40,000. Finally, CBIZ Investment Advisory Services LLC lifted its holdings in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after purchasing an additional 127 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.